| ADHD Directory |
| ADHD Printables |
| ADHD Webinars |
| ADHD Guides |
| Expert Answers |
| ADHD News |
| Tools and Checklists |
| ADHD Topics A-Z |
| Book Reviews |
 |
| ADHD Groups |
| ADHD Discussions |
| ADHD Blogs |
| Share Your Story |
| E-Newsletters |
| ADHD Events |
| ADHD Videos |
|
| Subscribe |
| Give a Gift |
| Current Issue |
| Digital |
| Archives |
| Buy Back Issues |
| Buy Booklets |
| Customer Service |
| Contact Us |
| Advertise |
Are Trial-and-Error Meds a Thing of the Past?Filed Under: ADHD Medication and Children
Q:
"My doctor says there's a new test to determine if medication will help a child. What is it?" 
A:
Last year, a research team at the Medical University of South Carolina reported that it discovered a gene mutation directly involved in the metabolism of methylphenidate (Ritalin). The researchers suggested that, some day, it might be possible for a genetic test to determine whether methylphenidate will be effective for a child with ADHD. It often takes a long time to develop inexpensive and convenient clinical applications from basic research findings. For now, we still determine which stimulant will work best by trial and experience. [Editor's Note: Read "Mutation Related to ADHD Drug Metabolism Discovered" at http://frd.musc.edu.]
Larry Silver, M.D., is the author of Dr. Larry Silver's Advice to Parents on AD/HD and The Misunderstood Child: Understanding and Coping with Your Child's Learning Disabilities. He is also a clinical professor of psychiatry at Georgetown Medical Center in Washington, D.C.
|
|
Print
